“Obviously, next year, there will be a further step down in terms of pricing from the V28 model.”

In context

“ident you can get back there. With the 2026 rates looking better, we're going to move into the final year of V28. How do I think about what the key elements are to get back to that long term growth rate? Andrew Witty : Yeah. Lisa, thanks so much for the question. So yes, so clearly, we were pleased to see the beginning of recognition of rate increases, which actually reflect reality, which we haven't seen for last couple of years. But hopefully that will continue to be the stance and the data will drive that in the way we saw this year. So very, very pleased to see that. Also pleased to see in the Medicaid books of business come to continue to see great engagement with states that they also adjust to make sure that those rates are appropriate for what we're seeing. So those are important. Obviously, next year, there will be a further step down in terms of pricing from the V28 model. So we can't ignore that. That's clearly a reality. But the way we'd look at this, Lisa, is that we are very, very much -- we see very much the end of this transition period in terms of having to absorb the amount of pressure. I mean, clearly, we're a leader in all of this marketplace. We're taking almost certainly a bigger fraction, if you will of the pressure because of our market leadership position here. We feel like we're very much getting through this. We obviously this year have picked up these two or three second order derivative effects, which we're going to do a much better job of anticipating and managing for as we go into 2026. And we think that an awful lot of the issue that we're seeing early in ‘25, we can fix in 2025 and help us deliver stronger performance for ‘26. And we”